Literature DB >> 15912368

Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection.

G Pollock1, K R Pennypacker, S Mémet, A Israël, S Saporta.   

Abstract

NF-kappaB is a ubiquitous nuclear transcription factor that regulates a number of physiological processes. NF-kappaB activity has been implicated in enhancing neuronal survival following CNS injury. The present study was conducted to test the hypothesis that NF-kappaB activity is up-regulated in neurons of the spinal cord in response to peripheral nerve transection. In this series of experiments, we used NF-kappaB reporter mice in which activation of NF-kappaB drives the expression of the lac-z gene. The response to injury of cells in the spinal cord was assessed by evaluating the number and distribution of beta-galalactosidase (beta-gal)-positive cells following sciatic nerve transection. The animals were randomly assigned to four groups, which were allowed to survive for one, three, five and ten days. Four mice that did not undergo sciatic nerve transection were assigned to each group to serve as controls. The total number of beta-gal-positive cells in the right and left dorsal and ventral horns were compared. The numbers of beta-gal-positive cells between the right and left sides were significantly different three and five days post axotomy (p<0.05). Double immunofluorescent labeling was utilized to characterize which cells showed NF-kappaB activity, and it revealed that all beta-gal-positive cells were colocalized with MAP-2-positive neurons. The results of this study demonstrated that complete sciatic nerve transection leads to an up-regulation of NF-kappaB transactivation in spinal neurons ipsilateral to the side of transection. The increase in activity in the ipsilateral dorsal horn is consistent with this transcription factor acting as neuronal survival signal during this time frame in response to the peripheral nerve insult.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912368     DOI: 10.1007/s00221-005-2318-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  54 in total

1.  Mechanism of NF-kappaB inactivation induced by survival signal withdrawal in cerebellar granule neurons.

Authors:  Attila D Kovács; Shikha Chakraborty-Sett; Servio H Ramirez; Lynn F Sniderhan; Andrea L Williamson; Sanjay B Maggirwar
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

2.  Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine.

Authors:  Tomosada Sugimoto; Gary J Bennett; Keith C Kajander
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

3.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

4.  Reduced nuclear factor kappaB (p65) expression in rat primary sensory neurons after peripheral nerve injury.

Authors:  C A Doyle; S P Hunt
Journal:  Neuroreport       Date:  1997-09-08       Impact factor: 1.837

Review 5.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2.

Authors:  M Tamatani; N Mitsuda; H Matsuzaki; H Okado; S Miyake; M P Vitek; A Yamaguchi; M Tohyama
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

7.  Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse.

Authors:  L Li; R W Oppenheim; M Lei; L J Houenou
Journal:  J Neurobiol       Date:  1994-07

8.  I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.

Authors:  P A Ganchi; S C Sun; W C Greene; D W Ballard
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

9.  Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection.

Authors:  L Liu; J K Persson; M Svensson; H Aldskogius
Journal:  Glia       Date:  1998-07       Impact factor: 7.452

10.  Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries.

Authors:  W Ma; M A Bisby
Journal:  Brain Res       Date:  1998-06-29       Impact factor: 3.252

View more
  19 in total

1.  Nuclear factor-κB activation in Schwann cells regulates regeneration and remyelination.

Authors:  Paul D Morton; Joshua T Johnstone; Angel Y Ramos; Daniel J Liebl; Mary Bartlett Bunge; John R Bethea
Journal:  Glia       Date:  2012-01-24       Impact factor: 7.452

Review 2.  Multiple transcription factor families regulate axon growth and regeneration.

Authors:  Darcie L Moore; Jeffrey L Goldberg
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

3.  Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.

Authors:  Nitish D Fagoe; Jessica van Heest; Joost Verhaagen
Journal:  Neuromolecular Med       Date:  2014-10-01       Impact factor: 3.843

4.  Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia.

Authors:  Eunsoo Kim; Seon-Hee Hwang; Hae-Kyu Kim; Salahadin Abdi; Hee Kee Kim
Journal:  Mol Neurobiol       Date:  2019-04-29       Impact factor: 5.590

5.  R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids.

Authors:  Philipp Bishay; Helmut Schmidt; Claudiu Marian; Annett Häussler; Nina Wijnvoord; Simone Ziebell; Julia Metzner; Marco Koch; Thekla Myrczek; Ingo Bechmann; Rohini Kuner; Michael Costigan; Faramarz Dehghani; Gerd Geisslinger; Irmgard Tegeder
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

6.  Nuclear factor-kappaB activation in axons and Schwann cells in experimental sciatic nerve injury and its role in modulating axon regeneration: studies with etanercept.

Authors:  Darrell Smith; Christopher Tweed; Paul Fernyhough; Gordon W Glazner
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

7.  Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I).

Authors:  Marissa de Mos; André Laferrière; Magali Millecamps; Mercedes Pilkington; Miriam C J M Sturkenboom; Frank J P M Huygen; Terence J Coderre
Journal:  J Pain       Date:  2009-11       Impact factor: 5.820

8.  Effects of curcumin on pain threshold and on the expression of nuclear factor κ B and CX3C receptor 1 after sciatic nerve chronic constrictive injury in rats.

Authors:  Hong Cao; Jin-Wei Zheng; Jia-Jia Li; Bo Meng; Jun Li; Ren-Shan Ge
Journal:  Chin J Integr Med       Date:  2014-01-28       Impact factor: 1.978

9.  p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB.

Authors:  Iram Ahmad; Wei Ying Yue; Augusta Fernando; J Jason Clark; Erika A Woodson; Marlan R Hansen
Journal:  Glia       Date:  2014-06-26       Impact factor: 7.452

10.  Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain.

Authors:  Min K Lee; Seung R Han; Min K Park; Min J Kim; Yong C Bae; Sung K Kim; Jae S Park; Dong K Ahn
Journal:  Mol Pain       Date:  2011-08-05       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.